Logos Global Management LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:34 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 0 0.000% |
-3,500,000 (Position Closed) |
Filing |
| 2024-11-14 7:05 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 3,500,000 5.900% |
-150,000 (-4.11%) |
Filing |
| 2024-01-22 4:57 pm Purchase |
2024-01-10 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 3,650,000 8.600% |
3,650,000 (New Position) |
Filing |